Close X
Wednesday, October 2, 2024
ADVT 
International

Four Israeli soldiers killed in Rafah building explosion

Darpan News Desk IANS, 11 Jun, 2024 11:19 AM
  • Four Israeli soldiers killed in Rafah building explosion

Tel Aviv, June 11 (IANS/DPA) Four Israeli soldiers have been killed in an explosion at a building in Rafah in the south of the Gaza Strip, according to the Israeli military.

The army announced the deaths of the four men, aged between 19 and 24, on Tuesday.

According to Israeli media reports, the soldiers had thrown an explosive device into a suspicious three-storey building in Rafah to detonate possible booby traps. However, an explosion only occurred when the troops had already entered the building.

The building collapsed and buried several soldiers underneath it. Seven soldiers were also injured, some of them seriously.

The army later found a tunnel entrance in the building and said they believed that a high-ranking member of the Islamist Palestinian organisation Hamas had been living there.

During the operation in the coastal strip, Israeli soldiers went from house to house looking for weapons, among other things. According to the military, many buildings have been rigged with explosives.

According to the army, the incident on Tuesday means that 650 soldiers have been killed and more than 3,700 others injured on the Israeli side since October 7.

According to the Palestinian health authority, more than 37,100 Palestinians have been killed in the ensuing war.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK